H.R. 5745 · 117th Congress · House

COVID–19 Access to Testing and Support for Immune Response Research Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Oct 27, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

COVID-19 Access to Testing and Support for Immune Response Research Act of 2021

This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.

Action Timeline

6
  1. OCT 28, 2021•Committee

    Referred to the Subcommittee on Health.

  2. OCT 27, 2021•IntroReferral

    Introduced in House

  3. OCT 27, 2021•IntroReferral

    Introduced in House

  4. OCT 27, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. OCT 27, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. OCT 27, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Oct 28, 2021

Active

Health Subcommittee

hswm02

Referred: Oct 27, 2021

Active

Ways and Means Committee

hswm00

Referred: Oct 27, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Oct 27, 2021

Active